Are there indications for organ-preserving tumor resection in urothelial cancers of the upper urinary tract?;Gibt es indikationen zur organerhaltenden tumorresektion bei urothelkarzinomen des oberen harntraktes?

Aktuelle Urologie

Volumn 36, Issue 2, 2005, Pages 136-141

  Ubrig, B ^a   Renner, K ^a   Fallahi, M ^a   Roth, S ^a  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

Bladder; Neoplasm; Renal pelvis; Surgery; Transitional cell carcinoma; Ureter

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ELECTIVE SURGERY; FEMALE; FOLLOW UP; HUMAN; KIDNEY PELVIS CARCINOMA; MALE; RECURRENT CANCER; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; SURGICAL RISK; TRANSITIONAL CELL CARCINOMA; TREATMENT INDICATION; TREATMENT OUTCOME; TUMOR GROWTH; URETER CARCINOMA; URINARY TRACT CARCINOMA; URINARY TRACT SURGERY; UROTHELIUM;

AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; KIDNEY PELVIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEPHRECTOMY; RISK FACTORS; SURVIVAL ANALYSIS; URETER; URETERAL NEOPLASMS; UROGRAPHY;

EID: 20344371496     PISSN: 00017868     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-830277     Document Type: Article

References (27)

1. Strong DW, Pearse HD, Tank Jr ES, Hodges CV. The ureteral stump after nephroureterectomy. J Urol 1976; 115: 654-655
2. Zincke H, Neves RJ. Feasibility of conservative surgery for transitional cell cancer of the upper urinary tract. Urol Clin North Am 1984; 11: 717-724
3. Krogh J, Kvist E, Rye B. Transitional cell carcinoma of the upper urinary tract: prognostic variables and post-operative recurrences. Br J Urol 1991; 67: 32-36
4. Hall MC, Womack S, Sagalowsky AI et al. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology 1998; 52: 594-601
5. Park S, Hong B, Kim CS, Ahn H. The impact of tumor location on prognosis of transitional cell carcinoma of the upper urinary tract. J Urol 2004; 171: 621-625
6. Jabbour ME, Desgrandchamps F, Cazin S et al. Percutaneous management of grade II upper urinary tract transitional cell carcinoma: the long-term outcome. J Urol 2000; 163: 1105-1107
7. Goel MC, Mahendra V, Roberts JG. Percutaneous management of renal pelvic urothelial tumors: long-term follow-up. J Urol 2003; 169: 925-929
8. Elliott DS, Segura JW, Lightner D et al. Is nephroureterectomy necessary in all cases of upper tract transitional cell carcinoma? Long-term results of conservative endourologic management of upper tract transitional cell carcinoma in individuals with a normal contralateral kidney. Urology 2001; 58: 174-178
9. Chen GL, Bagley DH. Ureteroscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys. J Urol 2000; 164: 1173-1176
10. Gerber GS, Steinberg GD. Endourologic treatment of renal pelvic and ureteral transitional cell carcinoma. Tech Urol 1999; 5: 77-80
11. Deligne E, Colombel M, Badet L et al. Conservative management of upper urinary tract tumors. Eur Urol 2002; 42: 43-48
12. Suh RS, Faerber GJ, Wolf Jr JS. Predictive factors for applicability and success with endoscopic treatment of upper tract urothelial carcinoma. J Urol 2003; 170: 2209-2216
13. Iborra I, Solsona E, Casanova J et al. Conservative elective treatment of upper urinary tract tumors: a multivariate analysis of prognostic factors for recurrence and progression. J Urol 2003; 169: 82-85
14. Martinez-Pineiro JA, Garcia Matres MJ, Martinez-Pineiro L. Endourological treatment of upper tract urothelial carcinomas: analysis of a series of 59 tumors. J Urol 1996; 156: 377-385
15. Maier U, Mertl G, Pummer K et al. Organ-preserving surgery in patients with urothelial tumors of the upper urinary tract. Eur Urol 1990; 18: 197-200
16. Palou J, Piovesan LF, Huguet J et al. Percutaneous nephroscopic management of upper urinary tract transitional cell carcinoma: recurrence and long-term follow-up.J Urol 2004; 172: 66-69
17. Clark PE, Streem SB, Geisinger MA. 13-year experience with percutaneous management of upper tract transitional cell carcinoma. J Urol 1999; 161: 772-775
18. Jarrett TW, Sweetser PM, Weiss GH, Smith AD. Percutaneous management of transitional cell carcinoma of the renal collecting system: 9-year experience. J Urol 1995; 154: 1629-1635
19. Mazeman E. Tumours of the upper urinary tract calyces, renal pelvis and ureter. Eur Urol 1976; 2: 120-126
20. Keeley FX, Kulp DA, Bibbo M et al. Diagnostic accuracy of ureteroscopic biopsy in upper tract transitional cell carcinoma. J Urol 1997; 157: 33-37
21. Chen GL, El Gabry EA, Bagley DH. Surveillance of upper urinary tract transitional cell carcinoma: the role of ureteroscopy, retrograde pyelography, cytology and urinanalysis. J Urol 2000; 164: 1901-1904
22. Komatsu H, Tanabe N, Kubodera S et al. The role of lymphadenectomy in the treatment of transitional cell carcinoma of the upper urinary tract. J Urol 1997; 157: 1622-1624
23. Leissner J, Ghoneim MA, Abol-Enein H et al. Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J Urol 2004; 171: 139-144
24. Rey A, Lara PC, Redondo E et al. KI67 proliferation index in tumors of the upper urinary tract as related to established prognostic factors and long-term survival. Arch Esp Urol 1998; 51: 204-210
25. Lee SH, Lin JS, Tzai TS et al. Prognostic factors of primary transitional cell carcinoma of the upper urinary tract. Eur Urol 1996; 29: 266-270
26. Kamai T, Kawakami S, Koga F et al. RhoA is associated with invasion and lymph node metastasis in upper urinary tract cancer. BJU Int 2003; 91: 234-238
27. Patel A, Fuchs GJ. New techniques for the administration of topical adjuvant therapy after endoscopic ablation of upper urinary tract transitional cell carcinoma. J Urol 1998; 159: 71-75